{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:02:21Z","timestamp":1773795741699,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the incubation program of General Hospital of Western Theater command","award":["2021-XZYG-C45"],"award-info":[{"award-number":["2021-XZYG-C45"]}]},{"name":"the incubation program of General Hospital of Western Theater command","award":["2021-XZYG-C46"],"award-info":[{"award-number":["2021-XZYG-C46"]}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2024NSFSC1292"],"award-info":[{"award-number":["2024NSFSC1292"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2021YJ0145"],"award-info":[{"award-number":["2021YJ0145"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the general program of General Hospital of Western Theater Command","award":["2021-XZYG-B32"],"award-info":[{"award-number":["2021-XZYG-B32"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-025-05458-x","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T13:20:29Z","timestamp":1767619229000},"page":"1251-1263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SETD2 inhibited T-cell acute lymphocytic leukemia invasion and infiltration by inhibiting the JAK\/STAT pathway"],"prefix":"10.1007","volume":"481","author":[{"given":"Ling","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihui","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baitao","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangyi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"1","key":"5458_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.blre.2017.08.006","volume":"32","author":"E Vadillo","year":"2018","unstructured":"Vadillo E, Dorantes-Acosta E, Pelayo R et al (2018) T cell acute lymphoblastic leukemia (T-ALL): new insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies. Blood Rev 32(1):36\u201351","journal-title":"Blood Rev"},{"issue":"1","key":"5458_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00613-9","volume":"12","author":"T Steiml\u00e9","year":"2022","unstructured":"Steiml\u00e9 T, Dourthe ME, Alcantara M et al (2022) Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins. Blood Cancer J 12(1):14","journal-title":"Blood Cancer J"},{"issue":"1","key":"5458_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/13543784.2023.2161361","volume":"32","author":"X Thomas","year":"2023","unstructured":"Thomas X (2023) T-cell acute lymphoblastic leukemia: promising experimental drugs in clinical development. Expert Opin Investig Drugs 32(1):37\u201352","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"5458_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11899-019-00501-3","volume":"14","author":"CM Mcmahon","year":"2019","unstructured":"Mcmahon CM, Luger SM (2019) Relapsed T cell ALL: current approaches and new directions. Curr Hematol Malignancy Rep 14(2):83\u201393","journal-title":"Curr Hematol Malignancy Rep"},{"issue":"7380","key":"5458_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature10725","volume":"481","author":"J Zhang","year":"2012","unstructured":"Zhang J, Ding L, Holmfeldt L et al (2012) The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481(7380):157\u201363","journal-title":"Nature"},{"issue":"6","key":"5458_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04352-9","volume":"79","author":"TM Molenaar","year":"2022","unstructured":"Molenaar TM, Van Leeuwen F (2022) SETD2: from chromatin modifier to multipronged regulator of the genome and beyond. Cell Mol Life Sci 79(6):346","journal-title":"Cell Mol Life Sci"},{"key":"5458_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1204463","volume":"14","author":"J He","year":"2023","unstructured":"He J, Xu T, Zhao F et al (2023) SETD2-H3K36ME3: an important bridge between the environment and tumors. Front Genet 14:1204463","journal-title":"Front Genet"},{"issue":"1","key":"5458_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-021-00193-0","volume":"5","author":"M Lu","year":"2021","unstructured":"Lu M, Zhao B, Liu M et al (2021) Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy. NPJ Precis Oncol 5(1):51","journal-title":"NPJ Precis Oncol"},{"issue":"11","key":"5458_CR9","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.7150\/jca.38391","volume":"11","author":"R Chen","year":"2020","unstructured":"Chen R, Zhao WQ, Fang C et al (2020) Histone methyltransferase SETD2: a potential tumor suppressor in solid cancers. J Cancer 11(11):3349\u201356","journal-title":"J Cancer"},{"key":"5458_CR10","doi-asserted-by":"crossref","unstructured":"Li W. Histone Methyltransferase SETD2 in Lymphoid Malignancy [M]\/\/Gallamini A, Juweid M. Lymphoma. Brisbane (AU); Exon Publications Copyright: The Authors.; The authors confirm that the materials included in this chapter do not violate copyright laws. Where relevant, appropriate permissions have been obtained from the original copyright holder(s), and all original sources have been appropriately acknowledged or referenced. (2021)","DOI":"10.36255\/exon-publications.lymphoma.2021.setd2-lymphoid-malignancy"},{"key":"5458_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.mce.2017.02.019","volume":"451","author":"TA Waldmann","year":"2017","unstructured":"Waldmann TA (2017) JAK\/STAT pathway directed therapy of T-cell leukemia\/lymphoma: inspired by functional and structural genomics. Mol Cell Endocrinol 451:66\u201370","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"5458_CR12","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1182\/asheducation-2016.1.580","volume":"2016","author":"EA Raetz","year":"2016","unstructured":"Raetz EA, Teachey DT (2016) T-cell acute lymphoblastic leukemia. Hematology 2016(1):580\u20138","journal-title":"Hematology"},{"issue":"9","key":"5458_CR13","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1007\/s00277-023-05245-y","volume":"102","author":"M Hu","year":"2023","unstructured":"Hu M, Liu R, Li J et al (2023) Clinical features and prognosis of pediatric acute lymphocytic leukemia with JAK-STAT pathway genetic abnormalities: a case series. Ann Hematol 102(9):2445\u201357","journal-title":"Ann Hematol"},{"issue":"1","key":"5458_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00428-022-03448-8","volume":"482","author":"AS Duffield","year":"2023","unstructured":"Duffield AS, Mullighan CG, Borowitz MJ (2023) International consensus classification of acute lymphoblastic leukemia\/lymphoma. Virchows Archiv Int J Pathol 482(1):11\u201326","journal-title":"Virchows Archiv Int J Pathol"},{"key":"5458_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/genes12081118","author":"V Bardelli","year":"2021","unstructured":"Bardelli V, Arniani S, Pierini V et al (2021) T-cell acute lymphoblastic leukemia: biomarkers and their clinical usefulness. Genes. https:\/\/doi.org\/10.3390\/genes12081118","journal-title":"Genes"},{"issue":"3","key":"5458_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2020.101193","volume":"33","author":"S Kimura","year":"2020","unstructured":"Kimura S, Mullighan CG (2020) Molecular markers in ALL: clinical implications. Best practice & research Clinical haematology 33(3):101193","journal-title":"Best practice & research Clinical haematology"},{"key":"5458_CR17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2011278118","author":"Q Zhu","year":"2021","unstructured":"Zhu Q, Yang Q, Lu X et al (2021) SETD2-mediated H3K14 trimethylation promotes ATR activation and stalled replication fork restart in response to DNA replication stress. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2011278118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5458_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2021.106155","volume":"144","author":"UTF Lam","year":"2022","unstructured":"Lam UTF, Chen ES (2022) Molecular mechanisms in governing genomic stability and tumor suppression by the SETD2 H3K36 methyltransferase. The international journal of biochemistry & cell biology 144:106155","journal-title":"The international journal of biochemistry & cell biology"},{"issue":"6","key":"5458_CR19","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/CEJ.0000000000000587","volume":"29","author":"S Kumari","year":"2020","unstructured":"Kumari S, Muthusamy S (2020) SETD2 as a regulator of N6-methyladenosine RNA methylation and modifiers in cancer. Eur J Cancer Prev 29(6):556\u201364","journal-title":"Eur J Cancer Prev"},{"issue":"31","key":"5458_CR20","doi-asserted-by":"publisher","first-page":"50719","DOI":"10.18632\/oncotarget.9368","volume":"7","author":"J Li","year":"2016","unstructured":"Li J, Duns G, Westers H et al (2016) SETD2: an epigenetic modifier with tumor suppressor functionality. Oncotarget 7(31):50719\u201334","journal-title":"Oncotarget"},{"key":"5458_CR21","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026468","author":"CC Fahey","year":"2017","unstructured":"Fahey CC, Davis IJ (2017) SETting the stage for cancer development: SETD2 and the consequences of lost methylation. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a026468","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"5458_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-020-00243-y","volume":"8","author":"J Sun","year":"2020","unstructured":"Sun J, Yu W, Zhang X (2020) Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia. Biomark Res 8(1):62","journal-title":"Biomark Res"},{"key":"5458_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20051029","author":"A Skucha","year":"2019","unstructured":"Skucha A, Ebner J, Grebien F (2019) Roles of SETD2 in leukemia-transcription, DNA-damage, and beyond. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20051029","journal-title":"Int J Mol Sci"},{"issue":"25","key":"5458_CR24","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1182\/blood.2019001963","volume":"135","author":"BY Chen","year":"2020","unstructured":"Chen BY, Song J, Hu CL et al (2020) SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS. Blood 135(25):2271\u201385","journal-title":"Blood"},{"issue":"12","key":"5458_CR25","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1002\/pro.3519","volume":"27","author":"R Morris","year":"2018","unstructured":"Morris R, Kershaw NJ, Babon JJ (2018) The molecular details of cytokine signaling via the JAK\/STAT pathway. Protein Sci 27(12):1984\u20132009","journal-title":"Protein Sci"},{"key":"5458_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cells8080854","author":"F Perner","year":"2019","unstructured":"Perner F, Perner C, Ernst T et al (2019) Roles of JAK2 in aging, inflammation, hematopoiesis and malignant transformation. Cells. https:\/\/doi.org\/10.3390\/cells8080854","journal-title":"Cells"},{"key":"5458_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.semcancer.2019.10.002","volume":"60","author":"Y Verhoeven","year":"2020","unstructured":"Verhoeven Y, Tilborghs S, Jacobs J et al (2020) The potential and controversy of targeting STAT family members in cancer. Semin Cancer Biol 60:41\u201356","journal-title":"Semin Cancer Biol"},{"key":"5458_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110275","volume":"92","author":"M El-Tanani","year":"2022","unstructured":"El-Tanani M, Al Khatib AO, Aladwan SM et al (2022) Importance of STAT3 signalling in cancer, metastasis and therapeutic interventions. Cell Signalling 92:110275","journal-title":"Cell Signalling"},{"issue":"16","key":"5458_CR29","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.3390\/cells11162618","volume":"11","author":"S Hashimoto","year":"2022","unstructured":"Hashimoto S, Hashimoto A, Muromoto R et al (2022) Central roles of STAT3-Mediated signals in onset and development of cancers: tumorigenesis and immunosurveillance. Cells 11(16):2618","journal-title":"Cells"},{"key":"5458_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106210","volume":"80","author":"P Xin","year":"2020","unstructured":"Xin P, Xu X, Deng C et al (2020) The role of JAK\/STAT signaling pathway and its inhibitors in diseases. Int Immunopharmacol 80:106210","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"5458_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01468-7","volume":"8","author":"C Xue","year":"2023","unstructured":"Xue C, Yao Q, Gu X et al (2023) Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal Transduct Target Ther 8(1):204","journal-title":"Signal Transduct Target Ther"},{"issue":"21","key":"5458_CR32","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1038\/onc.2012.347","volume":"32","author":"W Vainchenker","year":"2013","unstructured":"Vainchenker W, Constantinescu SN (2013) JAK\/STAT signaling in hematological malignancies. Oncogene 32(21):2601\u201313","journal-title":"Oncogene"},{"issue":"5","key":"5458_CR33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1590\/S0100-879X2008005000016","volume":"41","author":"BA Cardoso","year":"2008","unstructured":"Cardoso BA, G\u00edRIO A, Henriques C et al (2008) Aberrant signaling in T-cell acute lymphoblastic leukemia: biological and therapeutic implications. Braz J Med Biol Res 41(5):344\u201350","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"5458_CR34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3892\/ijmm.2020.4592","volume":"46","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Sun Y, Hou W et al (2020) The JAK2\/STAT3 pathway inhibitor, AG490, suppresses the abnormal behavior of keloid fibroblasts in vitro. Int J Mol Med 46(1):191\u2013200","journal-title":"Int J Mol Med"},{"issue":"1","key":"5458_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1911","volume":"11","author":"L Fan","year":"2021","unstructured":"Fan L, Zhou L (2021) AG490 protects cerebral ischemia\/reperfusion injury via inhibiting the JAK2\/3 signaling pathway. Brain Behav 11(1):e01911","journal-title":"Brain Behav"},{"issue":"Pt 3","key":"5458_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113582","volume":"143","author":"X Fang","year":"2024","unstructured":"Fang X, Zhang W, Liu C et al (2024) Inhibition of peritendinous adhesion through targeting JAK2-STAT3 signaling pathway: the therapeutic potential of AG490. Int Immunopharmacol 143(Pt 3):113582","journal-title":"Int Immunopharmacol"},{"key":"5458_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123656","volume":"373","author":"M Zhang","year":"2025","unstructured":"Zhang M, Yuan L, Yang X et al (2025) TRAF1 promotes the progression of Helicobacter pylori-associated gastric cancer through EGFR\/STAT\/OAS signalling. Life Sci 373:123656","journal-title":"Life Sci"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05458-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-025-05458-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05458-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T21:03:13Z","timestamp":1773781393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-025-05458-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["5458"],"URL":"https:\/\/doi.org\/10.1007\/s11010-025-05458-x","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study protocol was reviewed and the need for approval was waived by the Ethics Committee of People\u2019s Liberation Army The General Hospital of Western Theater Command. Informed consent was obtained from all subjects and\/or their legal guardian(s).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}